Abstract:Muscarinic acetylcholine receptor (mAChR) agonists have been used to treat glaucoma due to their intraocular pressure-lowering effects. Recently, it has been reported that retinal mAChRs activation can also stimulate neuroprotective pathways. PURPOSE:In our study, we evaluated the potential neuroprotective effect of L-satropane, a novel mAChR agonist, on retinal neuronal injury induced by cobalt chloride (CoCl2) and ischemia/reperfusion (I/R). METHODS:CoCl2-induced hypoxia injury in cultured cell models and I/R-induced retinal neuronal damage in rats in vivo were used to evaluate the abilities of L-satropane. In detail, we measured the occurrence of retinal pathological changes including molecular markers of neuronal apoptosis and Aβ expression. RESULTS:Pretreatment with L-satropane protects against CoCl2-induced neurotoxicity in PC12 and primary retinal neuron (PRN) cells in a dose-dependent manner by increasing retinal neuron survival. CoCl2 or I/R-induced cell apoptosis by upregulating Bax expression and downregulating Bcl-2 expression, which resulted in an increased Bax/Bcl-2 ratio, and upregulating caspase-3 expression/activity was significantly reversed by L-satropane treatment. In addition, L-satropane significantly inhibited the upregulation of Aβ production in both retinal neurons and tissue. We also found that I/R-induced histopathological retinal changes including cell loss in the retinal ganglion cell layer (GCL) and increased TUNEL positive retinal ganglion cells in GCL and thinning of the inner plexiform layer (IPL) and inner nuclear layer (INL) were markedly improved by L-satropane. The effects of L-satropane were largely abolished by the nonselective mAChRs antagonist atropine and M1-selective mAChR antagonist pirenzepine. CONCLUSION:These results demonstrated that L-satropane might be effective in preventing retinal neuron damage caused by CoCl2 or I/R. The neuroprotective effects of L-satropane may be attributed to decreasing cell apoptosis and Aβ production through activation of M1 mAChR.

Stereoselectivity of Satropane, a Novel Tropane Analog, on Iris Muscarinic Receptor Activation and Intraocular Hypotension.

Β-Methyltryptamine Provoking the Crucial Role of Strictosidine Synthase Tyr151-OH for Its Stereoselective Pictet−Spengler Reactions to Tryptoline-type Alkaloids

Quantitative Determination of A Novel Enantiomeric Tropane Analog, (-)-satropane, in Biological Fluids Using Liquid Chromatography/Tandem Mass Spectrometry

Strictosidine Synthase Triggered Enantioselective Synthesis of N-Substituted (S)-3,14,18,19-tetrahydroangustines As Novel Topoisomerase I Inhibitors.

Study of Ocular Pharmacokinetics of in Situ Gel System for S(-)-Satropane Evaluated by Microdialysis

Comparative Study on Pharmacokinetics of a Series of Anticholinergics, Atropine, Anisodamine, Anisodine, Scopolamine and Tiotropium in Rats.

[Design, Synthesis and Antiasthmatic Activities of NO-donating Seratrodast Derivatives].

Synthesis and Bioactivities of 3Α-Sulfonyloxy and Sulfonylamido Tropane Derivatives

L-Satropane Prevents Retinal Neuron Damage by Attenuating Cell Apoptosis and Aβ Production via Activation of M1 Muscarinic Acetylcholine Receptor.

Synthesis of Tropane Compounds and Their Antagonistic Activity and Tissue Selectivity to Trachea of Rats

The Effect of Absolute Configuration on Activity, Subtype Selectivity (M3/M2) of 3Α-Acyloxy-6β-acetoxyltropane Derivatives As Muscarinic M3 Receptor Antagonists

Synthesis and Bioactivities of 3Α-Substituted-6β-acetoxytropane Derivatives

Synthesis and Biological Activity of Tropane Derivatives

Synthesis and nicotinic acetylcholine receptor affinity of bivalent tropane-3-carboxylates

Synthesis, Activity Determination of Tropane Compounds As Muscarinic M3 Receptor Antagonists and Quantitative Relationship Between Their Molecular Structure and Activity

Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tangutica

Discovery Of Novel Potent Muscarinic M-3 Receptor Antagonists With Proper Plasma Stability By Structural Recombination Of Marketed M-3 Antagonists

Development of Nitric Oxide-Donating Netarsudil Derivatives As a Synergistic Therapy for Glaucoma with Reduced Ocular Irritation.

Effects of enantiomers (R,R)-XY and (S,S)-XY on ocular blood flow in rabbits

Novel 5-Hydroxytryptamine (5-HT3) Receptor Antagonists. III. Pharmacological Evaluations and Molecular Modeling Studies of Optically Active 4,5,6,7-Tetrahydro-1H-benzimidazole Derivatives.

Racemic Bisindole Alkaloids: Structure, Bioactivity, and Computational Study